Skip to main content
David Young, MD, Oncology, Rancho Mirage, CA

DavidEugeneYoungMD

Oncology Rancho Mirage, CA

Physician

Dr. Young is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Young's full profile

Already have an account?

  • Office

    34490 Bob Hope Dr
    Rancho Mirage, CA 92270

Summary

  • Dr. David Young is an oncologist based in Rancho Mirage, CA, specializing in hematologic oncology with extensive experience in conditions such as amyloidosis, myelodysplasia, myelofibrosis, and multiple myeloma. He completed his fellowship in hematology and medical oncology at the University of California Davis Health and Los Angeles County-Harbor-UCLA Medical Center after finishing his residency and internship in internal medicine at San Joaquin General Hospital. A graduate of the University of Illinois College of Medicine.

    Retired

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Hematology and Medical Oncology, 1988 - 1989
  • Los Angeles County-Harbor-UCLA Medical Center 1
    Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1986 - 1988
  • San Joaquin General Hospital
    San Joaquin General HospitalResidency, Internal Medicine, 1980 - 1983
  • San Joaquin General Hospital
    San Joaquin General HospitalInternship, Transitional Year, 1979 - 1980
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2026
  • AR State Medical License
    AR State Medical License 1999 - 2001
  • TN State Medical License
    TN State Medical License 1998 - 2001
  • CO State Medical License
    CO State Medical License 1983 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014

Clinical Trials

Publications & Presentations

Abstracts/Posters

  • Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
    David E. Young, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • PROCESSA PHARMACEUTICALS : ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117 (Form 8-K)
    PROCESSA PHARMACEUTICALS : ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117 (Form 8-K)June 17th, 2021
  • Processa Pharmaceuticals Enters into a Licensing Agreement with Ocuphire Pharma, Inc., for the Development of Rx-3117
    Processa Pharmaceuticals Enters into a Licensing Agreement with Ocuphire Pharma, Inc., for the Development of Rx-3117June 17th, 2021
  • Processa Pharmaceuticals Entered into a Contingent Precedent in-Licensing Agreement with Elion Oncology for the Development of Eniluracil (pcs6422) for the Treatment of Advanced Gastrointestinal...
    Processa Pharmaceuticals Entered into a Contingent Precedent in-Licensing Agreement with Elion Oncology for the Development of Eniluracil (pcs6422) for the Treatment of Advanced Gastrointestinal...August 27th, 2020
  • Join now to see all